HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

Effectiveness and safety of percutaneous sclerotherapy using absolute ethanol and/or polidocanol for maxillofacial venous malformations involving the masticatory muscles : A case series

Files in This Item:
Manuscript.pdf807.27 kBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/92828

Title: Effectiveness and safety of percutaneous sclerotherapy using absolute ethanol and/or polidocanol for maxillofacial venous malformations involving the masticatory muscles : A case series
Authors: Ishikawa, Kosuke Browse this author →KAKEN DB
Sasaki, Satoru Browse this author
Furukawa, Hiroshi Browse this author
Maeda, Taku Browse this author
Miura, Takahiro Browse this author
Sasaki, Yuki Browse this author
Yamamoto, Yuhei Browse this author →KAKEN DB
Funayama, Emi Browse this author →KAKEN DB
Issue Date: 30-Jul-2022
Publisher: Elsevier
Journal Title: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Volume: 135
Issue: 3
Start Page: 355
End Page: 362
Publisher DOI: 10.1016/j.oooo.2022.07.013
Abstract: Objective. This study evaluated the effectiveness and safety of percutaneous sclerotherapy for maxillofacial venous malformations.Study Design. Patients with venous malformations involving the masticatory muscles who underwent sclerotherapy were enrolled in this retrospective study.Results. Twenty-four patients (13 female, 11 male; mean age 21 years) were analyzed. Major clinical symptoms were swelling (100%) and intralesional pain (54%). Intramuscular lesions involved the masseter muscle only in 38% of cases, both the masseter and temporalis muscles in 33%, all masticatory muscles in 21%, and the temporalis muscle only in 8%. Extramuscular involvement was observed in 58% of patients. Absolute ethanol and polidocanol were used as sclerosants. The mean number of sclerotherapy sessions per patient was 6.6 (range, 1-32). The mean follow-up duration after the first sclerotherapy session was 64.8 months (range, 6-178). Complications included paralysis of the facial nerve (25%), intraoral ulceration (8%), and hemoglobinuria (8%). Effectiveness of treatment was rated as excellent in 33% of cases, good in 46%, and fair in 21%. Better results were obtained in patients without extramuscular involvement.Conclusion. Percutaneous sclerotherapy can be effective and safe for maxillofacial intramuscular venous malformations, especially localized lesions of the masseter muscle.
Rights: ©2022.This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Type: article (author version)
URI: http://hdl.handle.net/2115/92828
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 石川 耕資

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 

 - Hokkaido University